We report here a series of new inhibitors of the X-linked inhibitor of apoptosis protein (XIAP protein) based on the SMAC-tetrapeptide AVPI. The structural novelty of these molecules is the presence of the proline mimetic exo-2-azabicyclo[2.2.1]heptane-3-carboxylic acid, leading to analogs with similar activity to the natural ligand peptide. The structure–activity relationship and computational docking studies support the convenience of this unnatural amino acid as a building block to develop new peptides or small molecules targeting the XIAP-BIR3 domain
Resistance against apoptosis-inducing anti-cancer drugs remains a severe problem in therapy. One rea...
Inhibitor of Apoptosis Proteins (IAPs) is highly conserved negative regulators of apoptosis overexpr...
Genetic alterations enhancing cell survival and suppressing apoptosis are hallmarks of cancer that s...
The X-linked inhibitor of apoptosis protein (XIAP) is overexpressed in several malignant cells where...
AbstractElevated expression of inhibitor of apoptosis protein (IAP) family members in various types ...
We report a second example of a general reaction screening approach to discover low molecular weight...
Defects in apoptosis regulation are one main cause of cancer development and may result from overexp...
Inhibitor of apoptosis proteins (IAPs) such as XIAP, cIAP1, and cIAP2 are upregulated in many cancer...
XIAP is a central apoptosis regulator that inhibits apoptosis by binding to and inhibiting the effec...
Programmed cell death (apoptosis) is the most common mechanism of cell death in eukaryotes. The abi...
We have designed and synthesized a cyclic, bivalent Smac mimetic (compound 3) and characterized its ...
SMAC (Secondary Mitochondria-derived Activator of Caspases) mimetics have generated significant inte...
University of Minnesota Ph.D. dissertation. December 2008. Major: Medicinal Chemistry. Advisor: Rodn...
XIAP is an apoptotic regulator protein that binds to the effector caspases -3 and -7 through its BIR...
Inhibitor of apoptosis proteins (IAPs) are negative regulators of apoptosis As IAPs are overexpresse...
Resistance against apoptosis-inducing anti-cancer drugs remains a severe problem in therapy. One rea...
Inhibitor of Apoptosis Proteins (IAPs) is highly conserved negative regulators of apoptosis overexpr...
Genetic alterations enhancing cell survival and suppressing apoptosis are hallmarks of cancer that s...
The X-linked inhibitor of apoptosis protein (XIAP) is overexpressed in several malignant cells where...
AbstractElevated expression of inhibitor of apoptosis protein (IAP) family members in various types ...
We report a second example of a general reaction screening approach to discover low molecular weight...
Defects in apoptosis regulation are one main cause of cancer development and may result from overexp...
Inhibitor of apoptosis proteins (IAPs) such as XIAP, cIAP1, and cIAP2 are upregulated in many cancer...
XIAP is a central apoptosis regulator that inhibits apoptosis by binding to and inhibiting the effec...
Programmed cell death (apoptosis) is the most common mechanism of cell death in eukaryotes. The abi...
We have designed and synthesized a cyclic, bivalent Smac mimetic (compound 3) and characterized its ...
SMAC (Secondary Mitochondria-derived Activator of Caspases) mimetics have generated significant inte...
University of Minnesota Ph.D. dissertation. December 2008. Major: Medicinal Chemistry. Advisor: Rodn...
XIAP is an apoptotic regulator protein that binds to the effector caspases -3 and -7 through its BIR...
Inhibitor of apoptosis proteins (IAPs) are negative regulators of apoptosis As IAPs are overexpresse...
Resistance against apoptosis-inducing anti-cancer drugs remains a severe problem in therapy. One rea...
Inhibitor of Apoptosis Proteins (IAPs) is highly conserved negative regulators of apoptosis overexpr...
Genetic alterations enhancing cell survival and suppressing apoptosis are hallmarks of cancer that s...